Final Selection of Development Project (market expansion type) (BIG3 policy designation type) | |
---|---|
Final Selection of Development Project (market expansion type) (BIG3 policy designation
type) by the Ministry of SMEs and Startups The Development project of ACPI linked HIS
was finally selected for the small and medium-sized business technology
innovation development project (market expansion type) (BIG3 policy designation
type) by the Ministry of SMEs and Startups. Regardless of the selection of this
project, we have already begun and completed development of manual ACPi, and
are proceeding with approval from the Ministry of Food and Drug Safety. Manual
ACPi is a drug injection pump, Anyfusion V-100 model, and only the UI for
anticancer drug preparation has been changed, and the kit can be prepared with
Anyfusion cartridge, so rapid approval is expected. We have provided concept information and
video information to many hospitals, Our device is different from the existing
anticancer drug preparation robot, and the anticancer drug preparation robot is
forcused in a specific field, and the amount of preparation is limited compared
to the price. ACPi is composed of Manual ACPi, semi-automatic
ACPi and full automatic AACPi, which are linked HIS, and hospitals recognized
that our device is capable of not only dispensing powders and bottles, but also
filling drugs into PCA balloons in clean rooms. Even hospitals that have
already decided to purchase robots have given their intentions to purchase
them. ACPi, Anyfusion H-100 linked HIS, can be injected to patients without
disconnection of kit from bottle or bag, which dramatically reduces human error
and Hospitals, MD, Nurse as well as hospital management understand the
Anyfusion platform business and are actively giving demands to us. ACPi has solved the difficulty and
inconvenience of extracting anticancer drugs, and the inability to expose oil
vapors and reducing the risk of medical accidents in syringes, and also solved
the impossible difficulties in the field of pharmaceutical preparation, and is
being talked about as an innovative product that cannot be replaced. It is more
meaningful that it is a domestic technology, and it is judged that it has the
conditions for active purchase at a low price compared to the amount of
preparation and cover and functions of all areas. We will do our best to faithfully reflect
the opinions of consumers, develop products that satisfy consumers, and solve
the challenges of anticancer drug manufacturers. Thank you. |
Next | Selected as a participating company by PHI Digital Healthcare and Yonsei Univ. Severance Hospital |
---|---|
Prev | Anyfusion Platform Business consultation with USA, Japan, Germany |